Janus Adler Hyldebrandt Selected Research

Janus Adler Hyldebrandt Research Topics

4	Heart Failure 10/2019 - 09/2015
2	Pulmonary Hypertension 06/2021 - 10/2019
2	Pulmonary Valve Insufficiency (Insufficiency, Pulmonary Valve) 09/2015 - 06/2010
1	Cardiogenic Shock 08/2020
1	Right Ventricular Dysfunction 01/2020
1	Hypoxia (Hypoxemia) 10/2019
1	Hypertrophy 10/2019
1	Pulmonary Arterial Hypertension 01/2019
1	Pleural Effusion (Pleural Effusions) 09/2017
1	Myocardial Stunning (Stunned Myocardium) 12/2016
1	Ischemia 12/2016
1	Pathologic Constriction (Stenosis) 06/2010

3	Norepinephrine (Noradrenaline)FDA LinkGeneric 06/2021 - 09/2017
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2020 - 12/2016
1	Dobutamine FDA LinkGeneric 06/2021
1	Bicarbonates (Hydrogen Carbonate)IBA 01/2020
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 10/2019
1	Semaxinib (SU5416)IBA 10/2019
1	sacubitril and valsartan sodium hydrate drug combinationIBA 10/2019
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 10/2019
1	Neprilysin (Neutral Endopeptidase)IBA 10/2019
1	Antineoplastic Agents (Antineoplastics)IBA 01/2019
1	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 01/2019
1	Succinic Acid (Succinate)IBA 12/2016
1	Adenosine (Adenocard)FDA LinkGeneric 12/2016
1	Pyruvic Acid (Pyruvate)IBA 12/2016
1	HypoxanthineIBA 12/2016
1	XanthineIBA 12/2016
1	malic acid (malate)IBA 12/2016
1	Epinephrine (Adrenaline)FDA LinkGeneric 09/2015
1	Milrinone (Primacor)FDA LinkGeneric 09/2015
1	Dopamine (Intropin)FDA LinkGeneric 09/2015